Search
New frontiers in neuroscience: 10 years of progress at UTSW’s O’Donnell Brain Institute: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-obi-10-year-anniversary.html
In her new office at UT Southwestern Medical Center, Ceci Verbaarschot, Ph.D., sits among unpacked boxes and discusses the intricacies of a brain-computer interface she is developing. The device is designed to restore sensation and movement in the upper limbs of people who are paralyzed from the
AI can identify stroke types using clinical notes, study shows : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-ai-strokes.html
Using only text from doctors’ notes and radiology reports, an artificial intelligence (AI) program known as GPT-4o reliably identified patients’ types of strokes, UT Southwestern Medical Center researchers found.
Biomarkers linked to side effects from cancer immunotherapy
https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-immunotherapy-biomarkers.html
A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy.
UT Southwestern develops test to predict immunotherapy response in kidney cancer: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/predicting-immunotherapy-response-kidney-cancer.html
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.
AEDs often not used in cardiac arrest, even where they’re mandated: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/feb-aed-cardiac-arrest.html
Automated external defibrillators (AEDs) are underutilized during cardiac arrest episodes despite laws in some states requiring their availability in high-risk areas such as athletic facilities, researchers at UT Southwestern Medical Center found. The devices can save lives by shocking the heart
Two UT Southwestern researchers awarded HHMI Hanna H. Gray Fellowships: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/sept-wells-ramos-hhmi.html
Two postdoctoral researchers at UT Southwestern Medical Center are among 25 early-career scientists nationwide selected as Howard Hughes Medical Institute (HHMI) Hanna H. Gray Fellows for 2023.
Drug shows promise in overcoming endocrine therapy resistance in breast cancer : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-endocrine-therapy-resist.html
For patients with estrogen receptor (ER)-positive breast cancer, development of the so-called Y537S mutation signals that their disease has taken an aggressive course and may become resistant to endocrine therapy.
UTSW findings could lead to more effective CPR delivery
https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-more-effective-cpr.html
Simple changes in patient ventilation procedures during out-of-hospital cardiopulmonary resuscitation (CPR) could lead to a dramatic improvement in cardiac arrest survival rates.
Nanotechnology helps chemo pass the blood-brain barrier: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/oct-nanotechnology-helps-chemo.html
Combining a common chemotherapy drug with an experimental nanotechnology allowed the drug to cross the blood-brain barrier and increased the survival rate in a mouse model of glioblastoma up to 50%, a team led by researchers from UT Southwestern Medical Center and UT Dallas found.
UTSW researchers identify driver of inflammatory bowel disease: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/sept-inflammatory-bowel-disease.html
Researchers at UT Southwestern Medical Center have discovered an intracellular mechanism that converts protective intestinal cells into disease-driving pathogenic cells, a finding that could lead to improved treatments for patients with inflammatory bowel disease (IBD).